tamsulosin has been researched along with Prostatic Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, G; Gupta, S; Lal, J; Maikhuri, JP; Mandalapu, D; Pandey, D; Sharma, V; Sharma, VL; Shukla, M; Shukla, S; Siddiqi, MI; Singh, N; Singh, S; Tanpula, DK; Yadav, SK | 1 |
| Chiu, B; Chuang, YC; Chung, SD; Kuo, HC | 1 |
| Ilie, CP; Mischianu, DL; Pemberton, RJ | 1 |
| Benning, CM; Chon, J; Kyprianou, N | 1 |
| Hashimoto, T; Iijima, Y; Ishigooka, M; Nakada, T; Yaguchi, H | 1 |
1 review(s) available for tamsulosin and Prostatic Diseases
| Article | Year |
|---|---|
Painful ejaculation.
Topics: Ejaculation; Humans; Male; Orgasm; Pain; Pain Management; Pain Measurement; Prostatectomy; Prostatic Diseases; Sexual Dysfunctions, Psychological; Sulfonamides; Tamsulosin | 2007 |
4 other study(ies) available for tamsulosin and Prostatic Diseases
| Article | Year |
|---|---|
Novel aryl piperazines for alleviation of 'andropause' associated prostatic disorders and depression.
Topics: Androgen Antagonists; Andropause; Animals; Cell Line; Depression; Down-Regulation; Humans; Male; Molecular Docking Simulation; Piperazine; Piperazines; Prostatic Diseases; Rats; Receptors, Androgen | 2017 |
Re: Claus G. Roehrborn, Steven A. Kaplan, J. Stephen Jones, Joseph T. Wang, Tamara Bavendam, Zhonghong Guan. Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of
Topics: Adrenergic alpha-Antagonists; Calcinosis; Humans; Inflammation; Male; Middle Aged; Prostate; Prostatic Diseases; Prostatitis; Sulfonamides; Tamsulosin; Urinary Bladder, Overactive; Urologic Diseases | 2009 |
Effects of alpha(1)-adrenoceptor (alpha(1)-AR) antagonists on cell proliferation and apoptosis in the prostate: therapeutic implications in prostatic disease.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Apoptosis; Biopsy; Cell Division; Doxazosin; Humans; Male; Muscle, Smooth; Prazosin; Prostate; Prostatic Diseases; Prostatic Hyperplasia; Prostatic Neoplasms; Stromal Cells; Sulfonamides; Tamsulosin | 2000 |
Spinal substance P immunoreactivity is enhanced by acute chemical stimulation of the rat prostate.
Topics: Adrenergic alpha-Antagonists; Animals; Fixatives; Formaldehyde; Lumbar Vertebrae; Male; Pain; Prostate; Prostatic Diseases; Rats; Rats, Sprague-Dawley; Sacrococcygeal Region; Spinal Cord; Stimulation, Chemical; Substance P; Sulfonamides; Tamsulosin; Up-Regulation | 2002 |